India's pharma exports to UK seen rising 8.7% to $981 million after FTA: Pharmexcil

Zero-tariff access under the India-UK CETA is expected to boost generic medicine exports, strengthen supply chains and deepen investment and R&D partnerships

Cadila reaffirms commitment to patient safety following regulatory communication on Aciloc

Company says active ingredient is clearly disclosed on all Aciloc packs and pledges full cooperation with authorities

NATCO Pharma raises stake in South Africa’s Adcock Ingram to 49%

Rs. 1,060-crore acquisition strengthens NATCO’s long-term growth strategy in the African pharmaceutical market

RPG Life Sciences partners with Archerchem to launch India’s first Naproxen–Esomeprazole combination

Exclusive marketing alliance brings gastro-protective pain management therapy for patients requiring long-term NSAID treatment

Alembic Pharma appoints M. Sai Kiran as General Manager – Distribution

Supply chain veteran with over 24 years of experience to strengthen distribution and logistics operations

Zydus Pinkathon makes a powerful comeback in Chennai with renewed focus on women’s health

The event will welcome women across age groups and fitness levels, reinforcing its message that health and fitness are for everyone

NATCO Pharma to raise stake in South Africa's Adcock Ingram to 49% in Rs. 1,069 crore deal

The acquisition strengthens NATCO Pharma's strategic presence in the African pharmaceutical market through Adcock Ingram, one of South Africa's leading pharmaceutical manufacturers and healthcare companies

Roche launches faster blood test for latent tuberculosis cutting diagnosis time to under 24 hours

Godavari Biorefineries secures Japan patent for breakthrough cancer therapy molecule

Bayer secures €3 billion Apollo investment to strengthen balance sheet

Apollo-managed funds and affiliates will acquire a minority, non-controlling stake in a newly established entity

Merck’s Lupus drug wins FDA breakthrough therapy designation

Novartis to acquire Myricx Bio in deal valued at up to $1.5 billion

The acquisition brings together Novartis’ global oncology capabilities with Myricx Bio’s pioneering N-myristoyltransferase inhibitor (NMTi) payload platform

Glenmark Pharma launches Olanzapine for injection expanding US injectable portfolio

The drug is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa IntraMuscular Injection

Dabur expects double-digit revenue growth in Q1 as India FMCG momentum strengthens

The India FMCG business maintained its growth momentum during the quarter

Europe pulls ahead as biopharma outsourcing shift accelerates away from US facilities

Meanwhile, US-based facilities have seen their share remain unchanged at 18% since 2024

Senores Pharma earns 2026 Great Place To Work certification

This prestigious certification is based entirely on the experiences shared by current employees of the company

Lonza to expand high-potency drug manufacturing capacity in Visp amid rising ADC demand

AbbVie wins key EU panel backing for RINVOQ in severe alopecia areata

A final decision from the European Commission is expected in the coming months

Aarti Pharmalabs inaugurates new manufacturing block at Tarapur

The new facility increases the company's xanthine derivatives manufacturing capacity to 9,600 TPA, positioning Aarti Pharmalabs among the world's top three manufacturers in the segment

Mankind Pharma and Denovo Sciences join hands to accelerate AI-powered drug discovery

The collaboration aims to shorten early drug discovery timelines, improve the quality of lead candidates, and increase the likelihood of clinical success by enabling better decision-making